Loading Results

Respiratory Disease

Showing   of 4 results

AlveoGene logo for thumbnail

AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

UH Harrington Discovery Institute included in partnership to create and fund new gene therapy company focused on inhaled gene therapy to treat rare respiratory diseases.

Key Mechanisms of Airway Relaxation in Asthma Revealed in New Study

Novel role for nitric oxide in treatment of asthma and other obstructive airway diseases detailed by team at University Hospitals and Case Western Reserve University.

UH Now Offering a Revolutionary Treatment Option for Patients with Severe COPD/Emphysema

Zephyr lung valve is the first FDA-approved device to help emphysema patients breathe easier without major surgery.

Athersys and UH Announce Activation of First Clinical Site for MACOVIA Study, a Pivotal Phase 2/3 Study Evaluating Multistem® Cell Therapy for COVID-19 Induced ARDS

University Hospitals Cleveland Medical Center, a nationally ranked hospital, is ready to start screening patients.

Results are loading...